The Multiple Sclerosis/Neuroimmunology Program in the Department of Neurology at Indiana University School of Medicine provides multidisciplinary care for individuals with multiple sclerosis and disorders of the central nervous system. The program coordinates care from neurologic, nursing, psychological, physical therapy, rehabilitation and urologic perspectives.
Clinical care incorporates the use of over 20 FDA-approved injectable, oral, and infusion maintenance immunotherapies for multiple sclerosis. Our program has been involved in the drug studies leading to approval of many of these therapies. We also employ state-of-the-art symptomatic treatments, including 4-aminopyridine, intrathecal baclofen for spasticity and robotic therapy.
The Multiple Sclerosis/Neuroimmunology research program participates in investigational new drug studies, looking for better treatments than already exist. Some trials are single-site studies at IU School of Medicine and others are part of national and international multicenter consortiums. Faculty physicians also collaborate with basic scientists at IU School of Medicine, and elsewhere, to investigate the underlying cause of multiple sclerosis and ways to monitor the disease.
Faculty and staff are involved in training medical students, residents, fellows, nurses, and advanced care providers, to care for multiple sclerosis patients and conduct research in multiple sclerosis.